scholarly journals Risk assessment of Genetically Modified Organisms (GMOs)

EFSA Journal ◽  
2012 ◽  
Vol 10 (10) ◽  
pp. s1008 ◽  
Author(s):  
Elisabeth Waigmann ◽  
Claudia Paoletti ◽  
Howard Davies ◽  
Joe Perry ◽  
Sirpa Kärenlampi ◽  
...  
2020 ◽  
Vol 38 (1) ◽  
pp. 22-28
Author(s):  
Philipp Kuehn ◽  
Thea Riebe ◽  
Lynn Apelt ◽  
Max Jansen ◽  
Christian Reuter

Novel environmental invasive biotechnologies, such as gene drives and Horizontal Environmental Genetic Alteration Agents exceed the classical applications of genetically modified organisms. The reason for this is that they are designed to transform wild organisms into genetically modified organisms which express desired traits. Instead of in a laboratory, this transformation takes place in the environment. The far-ranging effects that may be triggered by gene drive and Horizontal Environmental Genetic Alteration Agents require an extension of risk assessment to include socio-political consequences. The present article offers a first brief examination whether regulation is prepared for possible conflicts caused by benevolent or by hostile use of these novel technologies.


Author(s):  
Anne Saab

This chapter examines comparative approaches to risk assessment and regulation of genetically modified organisms (GMOs). It first provides a brief background on the emergence, increased use, and controversy surrounding GMOs as well as the important legal questions and complexities they raise before discussing the legal approaches used to assess and regulate risks associated with GM foods, labelling of GM foods, and the application of intellectual property rights (IPRs) to GMOs. In particular, it considers risk assessment in the United States and in the European Union, focusing on the precautionary approach versus the permissive approach. It also compares process regulation and product regulation for regulating the risks posed by GMOs in the United States and the European Union, along with risk assessment and regulation in Brazil, China, and Costa Rica. Finally, it analyses the legal framework for IPRs as they apply to GMOs and comparative approaches to patenting GMOs.


ISRN Ecology ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-13 ◽  
Author(s):  
Dhan Prakash ◽  
Sonika Verma ◽  
Ranjana Bhatia ◽  
B. N. Tiwary

Commercial potential of biotechnology is immense since the scope of its activity covers the entire spectrum of human life. The most potent biotechnological approach is the transfer of specifically constructed gene assemblies through various techniques. However, this deliberate modification and the resulting entities thereof have become the bone of contention all over the world. Benefits aside, genetically modified organisms (GMOs) have always been considered a threat to environment and human health. In view of this, it has been considered necessary by biosafety regulations of individual countries to test the feasibility of GMOs in contained and controlled environments for any potential risks they may pose. This paper describes the various aspects of risk, its assessment, and management which are imperative in decision making regarding the safe use of GMOs. Efficient efforts are necessary for implementation of regulations. Importance of the risk assessment, management, and precautionary approach in environmental agreements and activism is also discussed.


Sign in / Sign up

Export Citation Format

Share Document